Imperial Innovations completes quick-change to Touchstone
5th Jan 2017 16:45
(ShareCast News) - Imperial Innovations Group announced on Thursday that, further to the shareholder approval received at its AGM on 21 November 2016, the change of the company's name to Touchstone Innovations took effect on 4 January. The AIM-traded firm added that, with effect from 0800 GMT on Thu
Read moreImperial Innovations to change name to 'Touchstone'
28th Oct 2016 14:18
(ShareCast News) - Imperial Innovations Group announced on Friday that at its annual general meeting on 21 November, it will be seeking shareholder approval to change the name of the company to Touchstone Innovations. The AIM-traded group was originally formed as the technology transfer office for I
Read moreImperial Innovations celebrates investment momentum
24th Oct 2016 15:04
(ShareCast News) - Imperial Innovations Group noted on Monday that its portfolio company, Veryan Medical, has completed enrolment into the MIMICS-2 clinical study of its BioMimics 3D Self-Expanding Stent System. The AIM-traded firm said the MIMICS-2 study is a prospective, multicentre, interventiona
Read moreImperial Innovations' increases investments as pre-tax loss widens
13th Oct 2016 08:36
(ShareCast News) - Imperial Innovations' annual pre-tax loss widened while the technology commercialisation and investment company increased investments across its business with universities and a joint venture. For the year ended 31 July, the pre-tax loss widened to £63.1m from £15.1m, last year, w
Read moreImperial Innovations shares up on portfolio company progress
6th Oct 2016 15:15
(ShareCast News) - Imperial Innovations Group updated the market on Thursday, noting that its portfolio company TopiVert Pharma has announced that the first patients have been dosed in its Phase IIa proof-of-concept study to evaluate the safety, tolerability and efficacy of a rectal formulation of T
Read moreImperial Innovations sells Permasense portfolio business
3rd Oct 2016 15:20
(ShareCast News) - AIM-listed Imperial Innovations has sold its portfolio company Permasense to Fortune 500 company Emerson Electric for an initial consideration of £30.6m in cash. Further amounts of up to £10m may be paid in addition, subject to the Permasense business achieving certain performance
Read moreImperial Innovations invests £5.1m in new biotech start-up
21st Sep 2016 12:23
(ShareCast News) - AIM-listed technology investor Imperial Innovations invested £5.1m in Artios Pharma, a new biotech start-up launched on Wednesday. Imperial Innovations contributed £5.1m to the £25m series A funding round, giving it a 14.9% interest in the new Cambridge- based company. Artios, wh
Read moreDirector dealings: new Imperial Innovations chairman dips in
21st Jun 2016 09:25
(ShareCast News) - Imperial Innovations' chairman designate took the opportunity to buy shares in the company after they were hit by disappointing news about one of the company's investments. David Newlands, who is set to become non-executive chairman on 1 August, bought his first 100,000 shares at
Read moreImperial Innovations disappointed after Circassia drug test
20th Jun 2016 12:44
(ShareCast News) - Imperial Innovations noted top-line results from a Circassia Pharmaceuticals drug study on Monday, after Circassia's share price plummeted in the wake of the cat allergy treatment's failure to perform against a placebo. At 1230 BST, shares in Imperial were down 3.87% at 418.3p. I
Read moreImperial Innovations celebrates Cell Medica collaboration
17th Jun 2016 15:58
(ShareCast News) - Imperial Innovations celebrated success at one of its investee companies on Friday, noting the announcement from Cell Medica of an exclusive licensing agreement and co-development partnership with the Baylor College of Medicine to create next-generation cellular immunotherapy prod
Read moreImperial Innovations appoints David Newlands as chairman
11th May 2016 16:58
(ShareCast News) - Imperial Innovations announced a new chairman on Wednesday, appointing David Newlands to the post in a non-executive capacity with effect from the start of its new financial year - 1 August. The AIM-traded firm said that, after its announcement on 21 March that Dr Martin Knight wo
Read moreImperial Innovations investment in Stanmore Implants pays off
29th Apr 2016 15:39
(ShareCast News) - Imperial Innovations Group was looking forward to a cash windfall on Friday, as SIW Holdings sold its Stanmore Implants Worldwide business to Stryker Corporation for £35.6m. Through Imperial's interest in SIW Holdings, it will share in the net proceeds of around £4.8m once they ha
Read moreSmall caps news round-up
4th Feb 2016 15:50
(ShareCast News) - Forbidden Technologies was celebrating its first contract win for its social video platform on Thursday, after a number of proof-of-concept trials. The AIM-traded technology firm's 'eva' platform described itself as "the real video social network", and allows users to create profi
Read moreImperial Innovations proposes £100m fundraising
4th Feb 2016 10:51
(ShareCast News) - Imperial Innovations, the UK technology commercialisation and investment company, said on Thursday it has proposed a £100m fundraising by way of placing 425p new ordinary shares. The placing of 425p represents a premium of about 8.0% to the mid-market closing price of the group's
Read moreGSK, AstraZeneca and J&J join forces with universities for tech transfer fund
25th Jan 2016 15:21
(ShareCast News) - AstraZeneca, GlaxoSmithKline and Johnson & Johnson and three leading UK universities are joining forces to try to significantly improve the speed that academic scientific research is translated into new medicines. The University of Cambridge, Imperial College London and University
Read more